RxDoctor Payments Data

Thomas Wood, DO

Obstetrics & Gynecology · Fort Smith, ARNPI 1093844086

Payments from drug & device makers

What this record shows

This record is dominated by education: $9,015 of the $11,777 with a category attached, or 76.6%. Intuitive Surgical accounts for 86.9% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $7,760 and has fallen 99.3% since, to $54 in 2025. Among obstetrics & gynecology clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,777in general payments, 2019–2025

Across 100 payments — averaging $117.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$10K
  • AbbVie$643
  • Exeltis, USA Inc.$120
  • Mayne Pharma Commercial LLC$117
  • Hologic Sales And Service, LLC$64
  • Coloplast$57
  • plus $536 from 19 others

What the payments were for

  • Travel & lodging$1,22210%
  • Food & beverage$1,53913%
  • Education$9,01577%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,777 in reported general payments places this provider in the 95th percentile of 272 obstetrics & gynecology providers in Arkansas.

See all obstetrics & gynecology providers in Arkansas

Medicare billing

Part B allowed, 2024
$24,552
Medicare patients
145
Services billed
294

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated15$5,200
Estradiol65$1,652
Raloxifene Hcl14$446
ProgesteroneProgesterone, Micronized13$271
Levothyroxine Sodium11$54

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$43$5,20015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 272 obstetrics & gynecology providers in Arkansas.

Other obstetrics & gynecology in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →